Steven Woloshin, MD, MS, a professor of medicine and community and family medicine, and co-director of the Master of Health Care Delivery Science program at The Dartmouth Institute for Health Policy and Clinical Practice, discusses the controversy surrounding the FDA’s approval of Aducanumab—a new drug to treat mild Alzheimer disease.
Post Tagged with: "Steven Woloshin"
Dartmouth Study Assesses How Consumers Interpret and Act on Results from At-Home COVID-19 Self Tests
A new study by researchers at Dartmouth, Carnegie Mellon University, the University of Pittsburgh, and the Lisa Schwartz Foundation for Truth in Medicine, published in JAMA Internal Medicine, shows that people using COVID home test kits may fail to self-quarantine or may quarantine unnecessarily because they misinterpret the implications of test results.
Geisel Researcher Receives Grants to Improve News Media Reporting on Medical Research
Steven Woloshin, MD, MS, a professor of medicine, community and family medicine, and of The Dartmouth Institute, has received grants from the Arnold Foundation and the National Institute for Health Care Management to continue his work to train journalists for more reliable reporting on medical research.